The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Jacob Leonard S since 2007.
This trader's CIK number is 1049713.
At the time of last reporting, Jacob Leonard S was the Director of Antares Pharma, Inc.. (stock ticker symbol ATRS).
Also see all insider trading activities at Antares Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2007 | NYSE: BDY | 1,000 | $19,050 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ATRS | 0 | $0 | 15,321 | $77,371 | 15,321 | $34,319 |
| 2019 | ATRS | 0 | $0 | 336,892 | $1,409,478 | 272,078 | $331,600 |
| 2018 | ATRS | 0 | $0 | 0 | $0 | 32,407 | $27,545 |
| 2017 | ATRS | 0 | $0 | 271,762 | $1,052,419 | 260,362 | $216,462 |
| 2016 | ATRS | 50,000 | $36,000 | 0 | $0 | 0 | $0 |
| 2015 | ATRS | 0 | $0 | 23,500 | $63,024 | 0 | $0 |
| 2014 | ATRS | 10,000 | $19,800 | 11,400 | $57,570 | 11,400 | $5,700 |
| 2013 | ATRS | 0 | $0 | 17,000 | $68,000 | 0 | $0 |
| 2012 | ATRS | 10,000 | $34,390 | 0 | $0 | 0 | $0 |
| 2011 | ATRS | 17,000 | $28,910 | 0 | $0 | 0 | $0 |
| 2010 | ATRS | 10,000 | $15,200 | 0 | $0 | 0 | $0 |
| 2009 | ATRS | 5,000 | $5,350 | 0 | $0 | 0 | $0 |
| 2008 | ATRS | 20,000 | $9,600 | 0 | $0 | 0 | $0 |
| 2007 | ATRS | 20,000 | $23,800 | 0 | $0 | 0 | $0 |
1. Bradley Pharmaceuticals Inc (NYSE: BDY)
2. Antares Pharma, Inc. (ATRS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-03-30 | NYSE: BDY | Buy | 1,000 | 19.05 | 19,050 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-02-18 | ATRS | Option Ex | 15,321 | 2.24 | 34,319 |
| 2021-02-18 | ATRS | Sale | 15,321 | 5.05 | 77,371 |
| 2019-12-09 | ATRS | Sale | 244,814 | 4.63 | 1,133,244 |
| 2019-12-09 | ATRS | Option Ex | 160,000 | 1.63 | 260,799 |
| 2019-10-31 | ATRS | Option Ex | 20,000 | 1.10 | 22,000 |
| 2019-04-08 | ATRS | Sale | 92,078 | 3.00 | 276,234 |
| 2019-04-08 | ATRS | Option Ex | 92,078 | .53 | 48,801 |
| 2018-03-29 | ATRS | Option Ex | 32,407 | .85 | 27,545 |
| 2017-10-09 | ATRS | Option Ex | 218,600 | .68 | 147,555 |
| 2017-10-09 | ATRS | Sale | 230,000 | 4.05 | 931,730 |
| 2017-04-04 | ATRS | Option Ex | 21,762 | 1.65 | 35,907 |
| 2017-04-03 | ATRS | Sale | 20,000 | 2.88 | 57,580 |
| 2017-04-04 | ATRS | Sale | 21,762 | 2.90 | 63,109 |
| 2017-04-03 | ATRS | Option Ex | 20,000 | 1.65 | 33,000 |
| 2016-03-18 | ATRS | Buy | 50,000 | .72 | 36,000 |
| 2015-03-23 | ATRS | Sale | 19,100 | 2.68 | 51,188 |
| 2015-03-20 | ATRS | Sale | 4,400 | 2.69 | 11,836 |
| 2014-08-11 | ATRS | Buy | 10,000 | 1.98 | 19,800 |
| 2014-01-15 | ATRS | Sale | 11,400 | 5.05 | 57,570 |
| 2014-01-15 | ATRS | Option Ex | 11,400 | .50 | 5,700 |
| 2013-05-17 | ATRS | Sale | 17,000 | 4.00 | 68,000 |
| 2012-11-16 | ATRS | Buy | 10,000 | 3.44 | 34,390 |
| 2011-12-22 | AIS | Buy | 5,000 | 1.79 | 8,950 |
| 2011-08-12 | AIS | Buy | 2,000 | 2.06 | 4,120 |
| 2011-04-13 | AIS | Buy | 10,000 | 1.58 | 15,840 |
| 2010-08-16 | AIS | Buy | 5,000 | 1.59 | 7,950 |
| 2010-03-26 | AIS | Buy | 5,000 | 1.45 | 7,250 |
| 2009-12-15 | AIS | Buy | 5,000 | 1.07 | 5,350 |
| 2008-11-17 | AIS | Buy | 20,000 | .48 | 9,600 |
| 2007-11-19 | AIS | Buy | 5,000 | 1.09 | 5,450 |
| 2007-11-20 | AIS | Buy | 5,000 | 1.09 | 5,450 |
| 2007-08-20 | AIS | Buy | 10,000 | 1.29 | 12,900 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Jacob Leonard S (Director of Antares Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.